These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

372 related items for PubMed ID: 31530717

  • 1. Newborn Screening for Sickle Cell Disease Using Point-of-Care Testing in Low-Income Setting.
    Alvarez OA, Hustace T, Voltaire M, Mantero A, Liberus U, Saint Fleur R.
    Pediatrics; 2019 Oct; 144(4):. PubMed ID: 31530717
    [Abstract] [Full Text] [Related]

  • 2. Newborn blood spot screening for sickle cell disease by using tandem mass spectrometry: implementation of a protocol to identify only the disease states of sickle cell disease.
    Moat SJ, Rees D, King L, Ifederu A, Harvey K, Hall K, Lloyd G, Morrell C, Hillier S.
    Clin Chem; 2014 Feb; 60(2):373-80. PubMed ID: 24158758
    [Abstract] [Full Text] [Related]

  • 3. Extremely high birth prevalence of sickle cell disease in rural Tanzania.
    Eastburg L, Peckham A, Kawira E, Chirangi B, Adler D, Akungo BD, Smart LR, Ambrose EE.
    Pediatr Blood Cancer; 2020 Nov; 67(11):e28620. PubMed ID: 32803850
    [Abstract] [Full Text] [Related]

  • 4. Implementation of hospital-based sickle cell newborn screening and follow-up programs in Haiti.
    Alvarez OA, St Victor Dély N, Paul Hanna M, Saint Fleur R, Cetoute M, Metalonis S, Hustace T, Brown EC, Marcelin LH, Muscadin E, Eveillard R, Lerebours E.
    Blood Adv; 2024 Jan 09; 8(1):14-22. PubMed ID: 37820110
    [Abstract] [Full Text] [Related]

  • 5. Potential of point of care tests for newborn screening for sickle cell disease: Evaluation of HemotypeSC™ and sickle SCAN® in Tanzania.
    Christopher H, Josephat E, Kaywanga F, Saul S, Mshana I, Kunambi P, Nasser A, Chamba C, Makani J, Nkya S.
    Int J Lab Hematol; 2022 Oct 09; 44(5):959-965. PubMed ID: 35775883
    [Abstract] [Full Text] [Related]

  • 6. Point-of-care screening for sickle cell disease in low-resource settings: A multi-center evaluation of HemoTypeSC, a novel rapid test.
    Steele C, Sinski A, Asibey J, Hardy-Dessources MD, Elana G, Brennan C, Odame I, Hoppe C, Geisberg M, Serrao E, Quinn CT.
    Am J Hematol; 2019 Jan 09; 94(1):39-45. PubMed ID: 30290004
    [Abstract] [Full Text] [Related]

  • 7. Significant prevalence of sickle cell disease in Southwest Germany: results from a birth cohort study indicate the necessity for newborn screening.
    Kunz JB, Awad S, Happich M, Muckenthaler L, Lindner M, Gramer G, Okun JG, Hoffmann GF, Bruckner T, Muckenthaler MU, Kulozik AE.
    Ann Hematol; 2016 Feb 09; 95(3):397-402. PubMed ID: 26658910
    [Abstract] [Full Text] [Related]

  • 8. A Paper-Based Test for Screening Newborns for Sickle Cell Disease.
    Piety NZ, George A, Serrano S, Lanzi MR, Patel PR, Noli MP, Kahan S, Nirenberg D, Camanda JF, Airewele G, Shevkoplyas SS.
    Sci Rep; 2017 Apr 03; 7():45488. PubMed ID: 28367971
    [Abstract] [Full Text] [Related]

  • 9. Newborn Screening for Sickle Cell Disease in Liberia: A Pilot Study.
    Tubman VN, Marshall R, Jallah W, Guo D, Ma C, Ohene-Frempong K, London WB, Heeney MM.
    Pediatr Blood Cancer; 2016 Apr 03; 63(4):671-6. PubMed ID: 26739520
    [Abstract] [Full Text] [Related]

  • 10. Early diagnosis of sickle cell disease at birth hospitals and vaccination centers in Angola using point-of-care tests.
    Olaniyan HS, Briscoe C, Muhongo M, Pascoal R, Armando A, Santos B, McGann PT.
    Blood Adv; 2023 Oct 10; 7(19):5860-5867. PubMed ID: 37399450
    [Abstract] [Full Text] [Related]

  • 11. Effectiveness of preoperative screening for sickle cell disease in a population with a newborn screening program: a cohort study.
    O'Leary JD, Odame I, Pehora C, Chakraborty P, Crawford MW.
    Can J Anaesth; 2013 Jan 10; 60(1):54-9. PubMed ID: 23104576
    [Abstract] [Full Text] [Related]

  • 12. Newborn Screening and Clinical Profile of Children With Sickle Cell Disease in a Tribal Area of Gujarat.
    Dave K, Desai S, Italia Y, Mukherjee MB, Mehta P, Desai G.
    Indian Pediatr; 2022 Mar 15; 59(3):230-233. PubMed ID: 35014619
    [Abstract] [Full Text] [Related]

  • 13. Simultaneous point-of-care detection of anemia and sickle cell disease in Tanzania: the RAPID study.
    Smart LR, Ambrose EE, Raphael KC, Hokororo A, Kamugisha E, Tyburski EA, Lam WA, Ware RE, McGann PT.
    Ann Hematol; 2018 Feb 15; 97(2):239-246. PubMed ID: 29147848
    [Abstract] [Full Text] [Related]

  • 14. Newborn screening and prophylactic interventions for sickle cell disease in 47 countries in sub-Saharan Africa: a cost-effectiveness analysis.
    Kuznik A, Habib AG, Munube D, Lamorde M.
    BMC Health Serv Res; 2016 Jul 26; 16():304. PubMed ID: 27461265
    [Abstract] [Full Text] [Related]

  • 15. Strategy linking several analytical methods of neonatal screening for sickle cell disease.
    Ducrocq R, Pascaud O, Bévier A, Finet C, Benkerrou M, Elion J.
    J Med Screen; 2001 Jul 26; 8(1):8-14. PubMed ID: 11373853
    [Abstract] [Full Text] [Related]

  • 16. Neonatal screening for sickle cell disease in France.
    Bardakdjian-Michau J, Bahuau M, Hurtrel D, Godart C, Riou J, Mathis M, Goossens M, Badens C, Ducrocq R, Elion J, Perini JM.
    J Clin Pathol; 2009 Jan 26; 62(1):31-3. PubMed ID: 19103855
    [Abstract] [Full Text] [Related]

  • 17. Implementing newborn screening for sickle cell disease as part of immunisation programmes in Nigeria: a feasibility study.
    Nnodu OE, Sopekan A, Nnebe-Agumadu U, Ohiaeri C, Adeniran A, Shedul G, Isa HA, Owolabi O, Chianumba RI, Tanko Y, Iyobosa JH, Adekile AD, Olopade OI, Piel FB.
    Lancet Haematol; 2020 Jul 26; 7(7):e534-e540. PubMed ID: 32589979
    [Abstract] [Full Text] [Related]

  • 18. HemoTypeSC, a low-cost point-of-care testing device for sickle cell disease: Promises and challenges.
    Nnodu O, Isa H, Nwegbu M, Ohiaeri C, Adegoke S, Chianumba R, Ugwu N, Brown B, Olaniyi J, Okocha E, Lawson J, Hassan AA, Diaku-Akinwumi I, Madu A, Ezenwosu O, Tanko Y, Kangiwa U, Girei A, Israel-Aina Y, Ladu A, Egbuzu P, Abjah U, Okolo A, Akbulut-Jeradi N, Fernandez M, Piel FB, Adekile A.
    Blood Cells Mol Dis; 2019 Sep 26; 78():22-28. PubMed ID: 30773433
    [Abstract] [Full Text] [Related]

  • 19. New approach to accurate interpretation of sickle cell disease newborn screening by applying multiple of median cutoffs and ratios.
    Allaf B, Patin F, Elion J, Couque N.
    Pediatr Blood Cancer; 2018 Sep 26; 65(9):e27230. PubMed ID: 29781571
    [Abstract] [Full Text] [Related]

  • 20. Newborn screening by tandem mass spectrometry confirms the high prevalence of sickle cell disease among German newborns.
    Lobitz S, Klein J, Brose A, Blankenstein O, Frömmel C.
    Ann Hematol; 2019 Jan 26; 98(1):47-53. PubMed ID: 30132072
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.